Halladay Benjamin
Esperion Therapeutics, Inc. · Chief Financial Officer
Halladay Benjamin is listed in public filings as officer: Chief Financial Officer. This Halladay Benjamin insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Esperion Therapeutics, Inc. (ESPR). Investors use Halladay Benjamin's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| $27k7.3k shares | SellDec 17, 2025 | $3.67 | -- | |
| $20k7k shares | SellSep 17, 2025 | $2.81 | -- | |
| $1211 shares | SellJul 17, 2025 | $1.12 | -- | |
| $8.3k7.2k shares | SellJun 17, 2025 | $1.15 | -- | |
| $88 shares | SellApr 17, 2025 | $0.964 | -- | |
| $5.2k3.5k shares | SellMar 18, 2025 | $1.48 | -- | |
| $2011 shares | SellFeb 19, 2025 | $1.86 | -- | |
| $209 shares | SellJan 17, 2025 | $2.27 | -- | |
| $7.9k3.2k shares | SellDec 17, 2024 | $2.42 | -- |